Eun-Joo Lee , Myeong-Mi Lee , SunYoung Park, Kyu-Shik Jeong
{"title":"Sirt2正调控诺特辛诱导的肌肉损伤后的肌肉再生","authors":"Eun-Joo Lee , Myeong-Mi Lee , SunYoung Park, Kyu-Shik Jeong","doi":"10.1016/j.yexmp.2022.104798","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Sirt2 regulates various biological processes by deacetylating target genes. Despite roles in regulating proliferation, cell cycle, and </span>glucose metabolism, which are closely associated with </span>skeletal muscle<span><span> physiology, Sirt2 functions in this tissue remain unclear. In this study, genetic deletion<span><span> of Sirt2 delayed muscle regeneration after Notexin-induced muscle injury. Gene expressions of </span>myogenic regulatory factors, including Myf5, </span></span>MyoD<span><span>, and Myogenin, and cell cycle regulators, such as </span>cyclin D1<span><span><span><span> and CDK2, were repressed in Sirt2 knockout mice after injury. Also, Sirt2 knockout mice presented </span>muscle atrophy after muscle injury which is associated with the down-regulation of anabolic signaling and the up-regulation of catabolic signaling, in particular, increased </span>atrogin1<span> transcriptional expression. Thus, Sirt2 positively regulated skeletal muscle regeneration after muscle injury by regulating transcriptional expression involved in myogenesis, cell cycle, and anabolic and catabolic signaling. Based on the in vivo analyses, Sirt2 could function as an interventional therapeutic for chronic </span></span>myopathy, which is characterized by impaired muscle regeneration and muscle atrophy.</span></span></span></p></div>","PeriodicalId":12176,"journal":{"name":"Experimental and molecular pathology","volume":"127 ","pages":"Article 104798"},"PeriodicalIF":3.7000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":"{\"title\":\"Sirt2 positively regulates muscle regeneration after Notexin-induced muscle injury\",\"authors\":\"Eun-Joo Lee , Myeong-Mi Lee , SunYoung Park, Kyu-Shik Jeong\",\"doi\":\"10.1016/j.yexmp.2022.104798\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span><span>Sirt2 regulates various biological processes by deacetylating target genes. Despite roles in regulating proliferation, cell cycle, and </span>glucose metabolism, which are closely associated with </span>skeletal muscle<span><span> physiology, Sirt2 functions in this tissue remain unclear. In this study, genetic deletion<span><span> of Sirt2 delayed muscle regeneration after Notexin-induced muscle injury. Gene expressions of </span>myogenic regulatory factors, including Myf5, </span></span>MyoD<span><span>, and Myogenin, and cell cycle regulators, such as </span>cyclin D1<span><span><span><span> and CDK2, were repressed in Sirt2 knockout mice after injury. Also, Sirt2 knockout mice presented </span>muscle atrophy after muscle injury which is associated with the down-regulation of anabolic signaling and the up-regulation of catabolic signaling, in particular, increased </span>atrogin1<span> transcriptional expression. Thus, Sirt2 positively regulated skeletal muscle regeneration after muscle injury by regulating transcriptional expression involved in myogenesis, cell cycle, and anabolic and catabolic signaling. Based on the in vivo analyses, Sirt2 could function as an interventional therapeutic for chronic </span></span>myopathy, which is characterized by impaired muscle regeneration and muscle atrophy.</span></span></span></p></div>\",\"PeriodicalId\":12176,\"journal\":{\"name\":\"Experimental and molecular pathology\",\"volume\":\"127 \",\"pages\":\"Article 104798\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2022-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and molecular pathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0014480022000612\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and molecular pathology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014480022000612","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/28 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
Sirt2 positively regulates muscle regeneration after Notexin-induced muscle injury
Sirt2 regulates various biological processes by deacetylating target genes. Despite roles in regulating proliferation, cell cycle, and glucose metabolism, which are closely associated with skeletal muscle physiology, Sirt2 functions in this tissue remain unclear. In this study, genetic deletion of Sirt2 delayed muscle regeneration after Notexin-induced muscle injury. Gene expressions of myogenic regulatory factors, including Myf5, MyoD, and Myogenin, and cell cycle regulators, such as cyclin D1 and CDK2, were repressed in Sirt2 knockout mice after injury. Also, Sirt2 knockout mice presented muscle atrophy after muscle injury which is associated with the down-regulation of anabolic signaling and the up-regulation of catabolic signaling, in particular, increased atrogin1 transcriptional expression. Thus, Sirt2 positively regulated skeletal muscle regeneration after muscle injury by regulating transcriptional expression involved in myogenesis, cell cycle, and anabolic and catabolic signaling. Based on the in vivo analyses, Sirt2 could function as an interventional therapeutic for chronic myopathy, which is characterized by impaired muscle regeneration and muscle atrophy.
期刊介绍:
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature''s most jealously guarded secrets on the pathologic basis of disease.
Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.